Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease

NCT00925587 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
358
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen